Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NXL is expected to report earnings to rise 2,545.45% to -291 cents per share on November 13
Q3'26
Est.
$-2.91
Q2'26
Missed
by $0.01
Q1'26
Beat
by $0.01
Q4'25
Missed
by $0.01
Q3'25
Missed
by $0.01
The last earnings report on August 12 showed earnings per share of -10 cents, missing the estimate of -10 cents. With 7.70K shares outstanding, the current market capitalization sits at 1.68M.